Finally, Ma et al. revealed that the anti-metastatic activity of flavonoid baicalein in breast cancer cells may be caused by the inhibition of EMT via downregulation of SATB1 and the Wnt/β-catenin pathway [60]. This evidence concerns the gene SATB1 and breast carcinoma.